A new report from Switzerland’s Federal Audit Office reveals that pharmaceutical discounts mandated by law are largely failing to reach insured patients. Parliamentarians are expressing outrage, with one MP labeling the situation “organised theft.” The audit found that despite negotiated price reductions, these savings are not being consistently passed on, effectively overcharging patients for medication. The findings raise serious questions about transparency and accountability within the Swiss healthcare system. Authorities are now facing pressure to investigate why discounts aren't being applied as intended and to ensure patients benefit from lower drug prices, as legally required. The SFAO report is expected to fuel debate over healthcare costs and the need for greater regulation in the pharmaceutical sector.